Antimicrobial Drugs

Introduction to Antimicrobial Drugs

Antimicrobial drugs are agents that interfere with the growth of microbes within a host, forming a cornerstone of modern medicine. Their development and use are guided by the principle of selective toxicity, which aims to kill or inhibit harmful microbes without damaging the host.

• Selective toxicity: The ability of a drug to target microbial cells without harming host cells.

• Chemotherapy: The use of chemical agents to treat disease, a term coined by Paul Ehrlich.

• Magic bullet: Ehrlich's concept of a drug that specifically targets pathogens.

History and Discovery of Antibiotics

The discovery of antibiotics revolutionized the treatment of infectious diseases. In 1928, Alexander Fleming discovered penicillin, produced by the mold Penicillium, which inhibits bacterial growth.

• Antibiotic: A substance produced by a microbe that, in small amounts, inhibits another microbe.

• Penicillin: The first antibiotic discovered, effective against many Gram-positive bacteria.

Representative Sources of Antibiotics

Antibiotics are derived from various microorganisms, including bacteria and fungi. The following table summarizes key sources:

Spectrum of Antimicrobial Activity

Narrow vs Broad Spectrum Antibiotics

Antimicrobial drugs vary in their spectrum of activity, which refers to the range of microorganisms they affect.

• Narrow-spectrum antibiotics: Effective against a limited group of microbes (e.g., only Gram-positive bacteria).

• Broad-spectrum antibiotics: Effective against a wide variety of microbes, including both Gram-positive and Gram-negative bacteria.

• Superinfection: The growth of a target pathogen that has developed resistance to an antibiotic, often opportunistic.

Classification Based on Mode of Action

Antimicrobial drugs can be classified as bacteriostatic (inhibit growth) or bactericidal (kill bacteria), and by their spectrum of action.

• Bacteriostatic: Inhibit the growth and reproduction of bacteria.

• Bactericidal: Kill bacteria directly.

Modes of Action of Antimicrobial Drugs

Five Main Modes of Action

Antimicrobial drugs target specific sites in microbial cells, leading to their inhibition or death. The five main modes of action are:

1. Inhibition of cell wall synthesis: Drugs like penicillins, cephalosporins, and vancomycin disrupt peptidoglycan formation, weakening the cell wall.

2. Inhibition of protein synthesis: Drugs such as chloramphenicol, erythromycin, tetracyclines, and streptomycin interfere with ribosomal function.

3. Inhibition of nucleic acid replication and transcription: Quinolones and rifampin target DNA and RNA synthesis.

4. Injury to plasma membrane: Polymyxin B and lipopeptides disrupt membrane integrity.

5. Inhibition of essential metabolite synthesis: Sulfonamides and trimethoprim block metabolic pathways.

Inhibitors of Cell Wall Synthesis

Cell wall synthesis inhibitors are particularly effective against bacteria due to their unique peptidoglycan structure.

• Penicillins: Include natural, semisynthetic, and extended-spectrum types.

• Cephalosporins: Classified into generations based on spectrum and administration route.

• Polypeptide antibiotics: Vancomycin is a glycopeptide used as a last line against resistant S. aureus.

• Antimycobacterial antibiotics: Isoniazid inhibits mycolic acid synthesis in mycobacteria.

Penicillins: Structure and Types

Penicillins contain a β-lactam ring, which is essential for their activity. Penicillinase (β-lactamase) can inactivate penicillins by breaking this ring.

• Natural penicillins: Penicillin G (injection), Penicillin V (oral); narrow spectrum, susceptible to penicillinase.

• Semisynthetic penicillins: Modified to resist penicillinase or broaden spectrum (e.g., oxacillin, ampicillin).

Inhibitors of Protein Synthesis

Protein synthesis inhibitors target the bacterial ribosome, which differs from eukaryotic ribosomes, allowing selective toxicity.

• Streptomycin: Changes shape of 30S ribosomal subunit, causing misreading of mRNA.

• Tetracyclines: Interfere with tRNA attachment to the ribosome-mRNA complex.

• Chloramphenicol: Binds to 50S subunit, inhibiting peptide bond formation.

Inhibitors of Nucleic Acid Synthesis

These drugs interfere with DNA and RNA synthesis, essential for microbial replication.

• Rifamycin: Inhibits mRNA synthesis; used for tuberculosis and leprosy.

• Quinolones and fluoroquinolones: Inhibit DNA gyrase, blocking DNA replication; used for urinary tract infections and pneumonia.

Injury to the Plasma Membrane

Drugs targeting the plasma membrane cause structural changes, leading to cell death.

• Lipopeptides: Cause structural changes in Gram-positive bacterial membranes.

• Polymyxin B: Effective against Gram-negative bacteria; used topically.

Inhibition of Essential Metabolite Synthesis

Competitive inhibitors block key metabolic pathways by mimicking substrates.

• Sulfonamides: Inhibit folic acid synthesis by competing with PABA for enzyme binding.

Tests to Guide Chemotherapy

Diffusion Methods and Broth Dilution Tests

Laboratory tests help determine the effectiveness of antimicrobial drugs against specific pathogens.

• Disk diffusion (Kirby-Bauer) test: Measures zone of inhibition around antibiotic disks.

• E-test: Determines minimal inhibitory concentration (MIC).

• Broth dilution test: Determines minimal bactericidal concentration (MBC).

Effects of Drug Combinations

Synergism and Antagonism

Combining drugs can enhance or reduce their effectiveness.

• Synergism: The effect of two drugs together is greater than either alone.

• Antagonism: The effect of two drugs together is less than either alone.

Mechanisms of Microbial Resistance

Mechanisms of Resistance

Microbes can develop resistance to antibiotics through several mechanisms:

• Blocking entry: Modifying porins to prevent drug entry.

• Inactivation by enzymes: Enzymes like β-lactamase inactivate antibiotics.

• Alteration of target molecule: Minor modifications neutralize drug effects.

• Efflux of antibiotic: Membrane proteins pump drugs out of the cell.

Antibiotic Misuse and Prevention

Misuse of antibiotics accelerates resistance development. Prevention strategies include:

• Completing prescribed regimens

• Avoiding unnecessary prescriptions

• Using specific antibiotics instead of broad-spectrum agents

Future of Chemotherapeutic Agents

Emerging Strategies

New approaches to antimicrobial therapy include:

• Antimicrobial peptides

• Phage therapy

• Genetic targeting of microbes

Summary

Antimicrobial drugs are essential tools in controlling microbial infections. Understanding their mechanisms, spectrum, and resistance is crucial for effective therapy and prevention of resistance. Additional info: Academic context was added to clarify mechanisms, historical significance, and laboratory testing methods for antimicrobial drugs.